Showing 41 - 60 results of 20,715 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 0.73s Refine Results
  1. 41
  2. 42

    Oxytocin decreases locally evoked CeA GABAergic signaling and blunts alcohol effects. by Brendan J. Tunstall (6593357)

    Published 2019
    “…(B) Effect of 3 concentrations of oxytocin (100, 500, and 1,000 nM) on eIPSP amplitudes in CeA neurons from alcohol-nondependent and -dependent rats. …”
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48

    Oxytocin decreases postsynaptic CeA spontaneous GABAergic transmission and blocks presynaptic alcohol effects. by Brendan J. Tunstall (6593357)

    Published 2019
    “…(L) Representative sIPSCs of CeA neurons from dependent rats with the oxytocin receptor antagonist OTA (100 nM), during oxytocin (500 nM), and during subsequent coapplication of oxytocin with 44 mM alcohol. …”
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55

    Figure 5 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

    Published 2025
    “…MFI, mean fluorescence intensity. <b>D,</b> A schematic representation of perforin maturation. …”
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60

    Delphinidin alters VEGF-A splicing to increase VEGF-A<sub>165</sub>b and decrease total VEGF-A expression. by Megan Stevens (3964886)

    Published 2019
    “…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A<sub>165</sub>b relative to total VEGF-A<sub>165</sub> (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A<sub>165</sub>b before stripping and reprobing with panVEGF-A). …”